These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36899303)

  • 1. Diagnostic performance of diffusion-weighted imaging versus 18F-FDG PET/CT in differentiating pulmonary lesions: an updated meta-analysis of comparative studies.
    Liu J; Xia X; Zou Q; Xie X; Lei Y; Wan Q; Li X
    BMC Med Imaging; 2023 Mar; 23(1):37. PubMed ID: 36899303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.
    Ohno Y; Kishida Y; Seki S; Yui M; Miyazaki M; Koyama H; Yoshikawa T
    J Magn Reson Imaging; 2018 Apr; 47(4):1013-1021. PubMed ID: 28799280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.
    Li B; Li Q; Chen C; Guan Y; Liu S
    Acad Radiol; 2014 Jan; 21(1):21-9. PubMed ID: 24331261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted MRI versus FDG-PET/CT for diagnosing pancreatic cancer: an indirect comparison meta-analysis.
    Que R; Chen Y; Tao Z; Ge B; Li M; Fu Z; Li Y
    Acta Radiol; 2020 Nov; 61(11):1473-1483. PubMed ID: 32148066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
    Li B; Li Q; Nie W; Liu S
    Eur J Radiol; 2014 Feb; 83(2):338-44. PubMed ID: 24355655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.
    Ruilong Z; Daohai X; Li G; Xiaohong W; Chunjie W; Lei T
    Nucl Med Commun; 2017 Jan; 38(1):67-75. PubMed ID: 27741214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
    Mori T; Nomori H; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Oncol; 2008 Apr; 3(4):358-64. PubMed ID: 18379353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
    Zhang C; Liang Z; Liu W; Zeng X; Mo Y
    BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
    J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
    Shen G; Lan Y; Zhang K; Ren P; Jia Z
    PLoS One; 2017; 12(3):e0173104. PubMed ID: 28253364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses: comparison with positron emission tomography.
    Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Maeda S; Matoba M; Kuginuki Y; Taniguchi M; Tonami H; Ueda Y; Sakuma T
    Asian Pac J Cancer Prev; 2014; 15(11):4629-35. PubMed ID: 24969896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.
    Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Kassai Y; Yui M; Matsumoto S; Sugimura K
    Eur J Radiol; 2015 Nov; 84(11):2321-31. PubMed ID: 26231045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Performance of Whole-Body MRI and FDG PET/CT in Evaluation of Multiple Myeloma Treatment Response: Systematic Review and Meta-Analysis.
    Rama S; Suh CH; Kim KW; Durieux JC; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 Apr; 218(4):602-613. PubMed ID: 34704461
    [No Abstract]   [Full Text] [Related]  

  • 20. Indirect comparison of the diagnostic performance of
    Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J
    BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.